| NCT03050203 |
Custom Pack in Spine Surgery |
https://ClinicalTrials.gov/show/NCT03050203 |
Completed |
Istituto Ortopedico Rizzoli |
2016-06-16 |
| NCT04285229 |
A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT04285229 |
Recruiting |
Eli Lilly and Company |
2021-03-31 |
| NCT04169373 |
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT04169373 |
Recruiting |
AbbVie |
2023-02-20 |
| NCT04163016 |
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) |
https://ClinicalTrials.gov/show/NCT04163016 |
Recruiting |
UCB Pharma |
2022-08-31 |
| NCT03733925 |
A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis |
https://ClinicalTrials.gov/show/NCT03733925 |
Recruiting |
Johnson & Johnson Private Limited |
2021-01-25 |
| NCT03358134 |
Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03358134 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2017-07-31 |
| NCT03319264 |
Sarcopenia in Axial and Peripheral Spondyloarthropathies |
https://ClinicalTrials.gov/show/NCT03319264 |
Completed |
Hospices Civils de Lyon |
2018-07-04 |
| NCT03287596 |
Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI |
https://ClinicalTrials.gov/show/NCT03287596 |
Recruiting |
University Hospital, Bordeaux |
2022-04-01 |
| NCT03270501 |
Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation |
https://ClinicalTrials.gov/show/NCT03270501 |
Recruiting |
University Ghent |
2020-12-31 |
| NCT03253796 |
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (MK-8259-038) |
https://ClinicalTrials.gov/show/NCT03253796 |
Active, not recruiting |
Merck Sharp & Dohme Corp. |
2021-06-15 |
| NCT03248518 |
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03248518 |
Active, not recruiting |
University of Aberdeen |
2020-10-31 |
| NCT03190603 |
Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03190603 |
Completed |
Armed Forces Capital Hospital, Republic of Korea |
2018-06-05 |
| NCT03187444 |
Cardiovascular Risk and Chronic Inflammatory Rheumatism |
https://ClinicalTrials.gov/show/NCT03187444 |
Recruiting |
University Hospital, Clermont-Ferrand |
2036-10-24 |
| NCT03159767 |
A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03159767 |
Completed |
Western Health and Social Care Trust |
2018-05-02 |
| NCT03136861 |
SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis |
https://ClinicalTrials.gov/show/NCT03136861 |
Completed |
Novartis |
2019-02-15 |
| NCT03129100 |
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03129100 |
Active, not recruiting |
Eli Lilly and Company |
2020-05-26 |
| NCT03074656 |
The Norwegian Drug Monitoring Study |
https://ClinicalTrials.gov/show/NCT03074656 |
Active, not recruiting |
Diakonhjemmet Hospital |
2021-01-01 |
| NCT03072836 |
Study of Gut Microbiota in Crohn’s Disease Patients Suffering From Spondylarthritis |
https://ClinicalTrials.gov/show/NCT03072836 |
Recruiting |
Central Hospital, Nancy, France |
2020-05-15 |
| NCT03064815 |
The SpACE Study - Small Bowel Crohn’s Disease and Spondyloarthropathies |
https://ClinicalTrials.gov/show/NCT03064815 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2016-03-31 |
| NCT03033095 |
Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers |
https://ClinicalTrials.gov/show/NCT03033095 |
Completed |
University Hospital, Grenoble |
2017-07-31 |
| NCT03020992 |
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU |
https://ClinicalTrials.gov/show/NCT03020992 |
Completed |
UCB Pharma |
2019-12-04 |
| NCT02985983 |
A Study of KHK4827 in Subjects With Axial Spondyloarthritis (axSpA) |
https://ClinicalTrials.gov/show/NCT02985983 |
Completed |
Kyowa Kirin Co., Ltd. |
2019-09-23 |
| NCT02960035 |
A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02960035 |
Completed |
Sun Yat-sen University |
2016-09-30 |
| NCT02896127 |
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT02896127 |
Completed |
Novartis |
2018-05-14 |
| NCT02869100 |
Comparison of Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging of Spine and Sacroiliac Joints for Detection of Inflammatory Lesions in Spondyloarthritis Patients |
https://ClinicalTrials.gov/show/NCT02869100 |
Completed |
Central Hospital, Nancy, France |
2015-03-31 |
| NCT02855320 |
Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics |
https://ClinicalTrials.gov/show/NCT02855320 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-11-26 |
| NCT02818478 |
Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis |
https://ClinicalTrials.gov/show/NCT02818478 |
Completed |
Parker Research Institute |
2016-12-31 |
| NCT02771210 |
Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site |
https://ClinicalTrials.gov/show/NCT02771210 |
Completed |
Novartis |
2019-12-11 |
| NCT02757352 |
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02757352 |
Completed |
Eli Lilly and Company |
2019-03-01 |
| NCT02744014 |
Add-on Therapy for Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02744014 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2017-03-22 |
| NCT02696798 |
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02696798 |
Completed |
Eli Lilly and Company |
2018-05-18 |
| NCT02696785 |
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02696785 |
Completed |
Eli Lilly and Company |
2017-12-08 |
| NCT02696031 |
Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02696031 |
Active, not recruiting |
Novartis |
2019-07-01 |
| NCT02038426 |
Ultrasonography Assessment of Peripheral Entheses in Axial Spondyloarthritis and in Healthy Subjects, Athletes or Not |
https://ClinicalTrials.gov/show/NCT02038426 |
Completed |
Assistance Publique Hopitaux De Marseille |
2014-08-31 |
| NCT02573298 |
Cryotherapy and Doppler in Inflammatory Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT02573298 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2017-03-09 |
| NCT03926195 |
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03926195 |
Recruiting |
Galapagos NV |
2021-01-31 |
| NCT02552212 |
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS |
https://ClinicalTrials.gov/show/NCT02552212 |
Active, not recruiting |
UCB Pharma |
2018-04-30 |
| NCT02374749 |
COMorbidities and EDucation in SPondyloArthritis Study |
https://ClinicalTrials.gov/show/NCT02374749 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-10-16 |
| NCT02364479 |
Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein |
https://ClinicalTrials.gov/show/NCT02364479 |
Completed |
Sun Yat-sen University |
2016-07-28 |
| NCT02356874 |
The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis |
https://ClinicalTrials.gov/show/NCT02356874 |
Completed |
Diakonhjemmet Hospital |
2016-12-31 |
| NCT02154425 |
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers |
https://ClinicalTrials.gov/show/NCT02154425 |
Completed |
UCB Pharma |
2015-12-31 |
| NCT02148640 |
The NOR-SWITCH Study |
https://ClinicalTrials.gov/show/NCT02148640 |
Completed |
Diakonhjemmet Hospital |
2016-06-30 |
| NCT02098694 |
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT02098694 |
Completed |
Norwegian University of Science and Technology |
2015-04-30 |
| NCT02089529 |
Treatment of Axial Spondyloarthritis With Reduced Doses of NSAIDs |
https://ClinicalTrials.gov/show/NCT02089529 |
Completed |
University Hospital of North Norway |
2015-01-31 |
| NCT01298531 |
A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT01298531 |
Completed |
Pfizer |
2013-01-31 |
| NCT03359642 |
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy |
https://ClinicalTrials.gov/show/NCT03359642 |
Recruiting |
University Hospital, Bordeaux |
2021-06-30 |
| NCT03928704 |
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03928704 |
Recruiting |
UCB Pharma |
2021-02-02 |
| NCT02019602 |
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta |
https://ClinicalTrials.gov/show/NCT02019602 |
Completed |
UCB Pharma |
2016-10-31 |
| NCT01808118 |
Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT01808118 |
Completed |
AbbVie |
2017-02-21 |
| NCT01718951 |
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial |
https://ClinicalTrials.gov/show/NCT01718951 |
Completed |
Tuen Mun Hospital |
2014-03-31 |
| NCT01610947 |
Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity |
https://ClinicalTrials.gov/show/NCT01610947 |
Completed |
University Hospital, Montpellier |
2018-10-31 |
| NCT01590966 |
Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT01590966 |
Completed |
University Hospital, Ghent |
2019-03-26 |
| NCT01583374 |
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT01583374 |
Completed |
Amgen |
2014-02-24 |
| NCT01453725 |
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) |
https://ClinicalTrials.gov/show/NCT01453725 |
Completed |
Merck Sharp & Dohme Corp. |
2014-03-11 |
| NCT01426815 |
Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria |
https://ClinicalTrials.gov/show/NCT01426815 |
Completed |
University Hospital, Ghent |
2019-03-31 |
| NCT03622658 |
Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03622658 |
Completed |
Izana Bioscience Ltd. |
2020-02-04 |
| NCT04436640 |
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT04436640 |
Enrolling by invitation |
UCB Pharma |
2023-11-30 |
| NCT04200690 |
Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases |
https://ClinicalTrials.gov/show/NCT04200690 |
Recruiting |
University of Aarhus |
2022-07-31 |
| NCT04156620 |
Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA |
https://ClinicalTrials.gov/show/NCT04156620 |
Recruiting |
Novartis |
2021-08-09 |
| NCT04143165 |
Ultrasound Guided Epidural Block in Axial SPA |
https://ClinicalTrials.gov/show/NCT04143165 |
Completed |
Sohag University |
2020-01-12 |
| NCT04001673 |
Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis. |
https://ClinicalTrials.gov/show/NCT04001673 |
Completed |
Hôpital Cochin |
2018-09-15 |
| NCT03974308 |
Effectiveness of Spa Treatment, Outpatient Physiotherapy and no Physiotherapy in Spine Osteoarthritis |
https://ClinicalTrials.gov/show/NCT03974308 |
Enrolling by invitation |
University of Rzeszow |
2019-09-30 |
| NCT03932019 |
Study of Jitongning Tablet to Treat Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03932019 |
Recruiting |
Tasly Pharmaceuticals, Inc. |
2021-04-30 |
| NCT03906136 |
AScalate: Treat-to-target in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03906136 |
Recruiting |
Novartis |
2021-12-31 |
| NCT03762824 |
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease |
https://ClinicalTrials.gov/show/NCT03762824 |
Active, not recruiting |
Region Skane |
2018-09-03 |
| NCT03738956 |
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial |
https://ClinicalTrials.gov/show/NCT03738956 |
Recruiting |
Globe Pharmaceuticals Limited |
2018-12-30 |
| NCT03683602 |
Effect of Chosen Treatment Methods in Patients With Cervical Spine Osteoarthritis |
https://ClinicalTrials.gov/show/NCT03683602 |
Completed |
Jagiellonian University |
2013-04-30 |
| NCT03668925 |
Association Between Hidradenitis Suppurativa and Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03668925 |
Completed |
CHU de Reims |
2014-04-01 |
| NCT03639740 |
Treat-to-target With Secukinumab in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03639740 |
Recruiting |
Rigshospitalet, Denmark |
2021-02-28 |
| NCT03582332 |
Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients |
https://ClinicalTrials.gov/show/NCT03582332 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2016-06-23 |
| NCT03552276 |
A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis. |
https://ClinicalTrials.gov/show/NCT03552276 |
Active, not recruiting |
Sun Pharma Global FZE |
2023-06-30 |
| NCT03542955 |
Pulse Shortwave Therapy in Cervical Osteoarthritis |
https://ClinicalTrials.gov/show/NCT03542955 |
Completed |
BioElectronics Corporation |
2019-07-30 |
| NCT03486613 |
PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis |
https://ClinicalTrials.gov/show/NCT03486613 |
Completed |
Aalborg University Hospital |
2019-09-12 |
| NCT03473665 |
Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03473665 |
Completed |
Columbia University |
2019-08-02 |
| NCT03445845 |
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03445845 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2021-11-30 |
| NCT03430388 |
Yellow Fever Vaccine in Patients With Rheumatic Diseases |
https://ClinicalTrials.gov/show/NCT03430388 |
Completed |
University of Sao Paulo General Hospital |
2018-03-24 |
| NCT03425812 |
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission |
https://ClinicalTrials.gov/show/NCT03425812 |
Recruiting |
The First Affiliated Hospital of Xiamen University |
2020-01-20 |
| NCT03420404 |
Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03420404 |
Recruiting |
Singapore General Hospital |
2020-10-31 |
| NCT01258738 |
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes |
https://ClinicalTrials.gov/show/NCT01258738 |
Completed |
Pfizer |
2012-11-30 |
| NCT01174186 |
Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing |
https://ClinicalTrials.gov/show/NCT01174186 |
Completed |
Regionshospitalet Silkeborg |
2013-06-30 |
| NCT01087762 |
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT01087762 |
Completed |
UCB Pharma |
2011-10-31 |
| NCT01064856 |
Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA) |
https://ClinicalTrials.gov/show/NCT01064856 |
Completed |
AbbVie |
2011-08-31 |
| NCT01040195 |
Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain |
https://ClinicalTrials.gov/show/NCT01040195 |
Completed |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2012-11-30 |
| NCT01029847 |
Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT01029847 |
Completed |
Rigshospitalet, Denmark |
2013-12-31 |
| NCT00939003 |
Study of Adalimumab in Patients With Axial Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT00939003 |
Completed |
AbbVie |
2011-02-28 |
| NCT03092583 |
Analysis of DNA Methylation in Spondyloarthritis |
https://ClinicalTrials.gov/show/NCT03092583 |
Recruiting |
Centre Hospitalier Universitaire de Besancon |
2020-03-31 |
| NCT00844805 |
Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) |
https://ClinicalTrials.gov/show/NCT00844805 |
Completed |
Merck Sharp & Dohme Corp. |
2011-04-30 |
| NCT00722514 |
Evaluation of a Patient Education Program for Ankylosing Spondylitis |
https://ClinicalTrials.gov/show/NCT00722514 |
Completed |
Rehazentrum Bad Eilsen |
2001-02-28 |
| NCT00591201 |
Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies |
https://ClinicalTrials.gov/show/NCT00591201 |
Completed |
Hospital General de Mexico |
2007-06-30 |